A previous phase 2 trial has suggested that statins might delay brain atrophy in secondary progressive multiple sclerosis.
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1a therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)
TEDESCHI, Gioacchino;
2016
Abstract
A previous phase 2 trial has suggested that statins might delay brain atrophy in secondary progressive multiple sclerosis.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
